MSU
GSK icon

Maple Securities USA’s GSK GSK Stock Holding History

Maple Securities USA’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-3,884
Closed -$202K – 101
2015
Q2 		$202K Buy
+3,884
New +$219K 0.02% 230
2014
Q4 		– Sell
-15,053
Closed -$865K – 199
2014
Q3 		$865K Sell
15,053
-3,272
-18% -$201K 0.09% 57
2014
Q2 		$1.23M Buy
+18,325
New +$1.24M 0.14% 50
2014
Q1 		– Sell
-7,176
Closed -$479K – 250
2013
Q4 		$479K Sell
7,176
-15,813
-69% -$1.03M 0.03% 193
2013
Q3 		$1.44M Sell
22,989
-8,049
-26% -$518K 0.11% 147
2013
Q2 		$1.94M Buy
+31,038
New +$1.97M 0.18% 117

Other funds holding GSK

JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Maple Securities USA's GSK Position: Q3 2015 in Review

Maple Securities USA sold out of GSK (GSK) in Q3 2015, closing a stake of 3,884 shares — an estimated $202K sold.

Maple Securities USA first reported a position in GSK in Q2 2013 and held it in 6 quarters. The position peaked at $1.94M in Q2 2013. 706 funds tracked by Wall St. Rank hold GSK as of Q3 2015.

  • Maple Securities USA reported no remaining GSK position as of Q3 2015 after selling out during the quarter.
  • Maple Securities USA sold 3,884 GSK shares in Q3 2015, an estimated $202K.
  • Maple Securities USA first reported a position in GSK in Q2 2013 and held it in 6 quarters.
  • Maple Securities USA's GSK position peaked at $1.94M in Q2 2013.
  • 706 funds tracked by Wall St. Rank held GSK as of Q3 2015.

Based on Maple Securities USA's 13F filing for Q3 2015, filed 3 Nov 2015.